WST

NYSE West Pharmaceutical Services, Inc.

Nov 10, 2026 · 6:49 PM ET LAST TRADE Market Closed

$412.55 ↑ +0.00 (+0.00%) Trading Up from the previous close of $412.55, $2.86 below the day’s high of $415.41

YTD change: +49.94%
vs 20-day SMA: +4.17%
vs 200-day SMA: +29.78%

Price ranges

Previous day

$398.14 $415.40

open $403.07 close $413.09

+$10.02 (+2.49%)

Today

$408.80 $415.41

open $410.88 now $412.55

+$1.67 (+0.41%)

Past week

$386.88 $416.46

from $407.88 now $412.55

+$4.67 (+1.14%)

Past month

$367.50 $438.27

from $367.60 now $412.55

+$44.95 (+12.23%)

This year

$223.83 $438.27

from $275.14 now $412.55

+$137.41 (+49.94%)

Price & Performance

+90.79 (+28.17%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 13.2% away from all-time highs of $475.35
WST is up 50% since the beginning of the year
WST is up 50% over the past 12 months
WST is up 12% over the past 1 month
3% of all WST investors are betting against WST
Number of investors short WST has gone down 4% versus last month

WST reads very good: price sits above both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +50.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $2.66

Earnings momentum -16.1% Quarterly EPS growth

Quarterly change -16.1%

Valuation

P/E ratio 44.87

Enterprise value $29.1B

Beta 0.95

Balance sheet & scale

Income$638.9K

Revenue$3.4B

Cash$464.1M

Debt$313.9K

Income / Debt 2.04×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE

Sector Manufacturing

Sub Sector Miscellaneous Manufacturing

Market cap $28.7B

West Pharmaceutical Services, Inc. engages in the design, manufacture, and sale of containment and delivery systems for injectable drugs and healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. The Proprietary Products segment offers proprietary packaging, containment solutions, drug delivery systems, analytical lab services, and other integrated services and solutions, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Competitor comparison

Ticker	Company	Price	Change
JNJ.CAT	JOHNSON & JOHNSON CIBC CDR C REG S	$35.89	+2.11%
BDX	Becton, Dickinson and Company	$215.25	+1.59%
MDLN	Medline, Inc. Class A	$40.71	+2.70%
DXCM	DexCom, Inc.	$81.07	+2.09%
TRUMF	Terumo Corporation	$16.46	-2.80%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.